Edgewise Therapeutics
NASDAQ: EWTXBoulder, US · Founded 2017 · Delaware corporation · 1 known investors
Founders & leadership
KK
Kevin KochExecutive Officer, Director
PT
Peter ThompsonDirector
KH
Kenneth HarrisonDirector
JR
Jonathan RootDirector
AR
Alan RussellDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$95MraisedDec 2020 · 21 investors · BiotechnologyRule 506(b)
▶$95MraisedDec 2020 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin KochExecutive Officer, Director
- Peter ThompsonDirector
- Kenneth HarrisonDirector
- Jonathan RootDirector
- Alan RussellDirector
- Offering amount
- $95M
- Amount sold
- $95M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$25.1MraisedSep 2019 · 6 investors · Other TechnologyRule 506(b)
▶$25.1MraisedSep 2019 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin KochExecutive Officer, Director
- Peter ThompsonDirector
- Kenneth HarrisonDirector
- Jonathan RootDirector
- Alan RussellDirector
- Offering amount
- $50.1M
- Amount sold
- $25.1M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.